Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

Detecting N-ethyl-N-nitrosourea-induced mutation in the tissues of mice using whole-genome HiFi Sequencing
  • +3
  • Page McKinzie,
  • Jaime Miranda,
  • Stephen Dertinger,
  • Jeffrey Bemis,
  • Javier Revollo,
  • Vasily Dobrovolsky
Page McKinzie
NCTR

Corresponding Author:[email protected]

Author Profile
Jaime Miranda
NCTR
Author Profile
Stephen Dertinger
Litron Laboratories
Author Profile
Jeffrey Bemis
Litron Laboratories
Author Profile
Javier Revollo
National Center for Toxicological Research
Author Profile
Vasily Dobrovolsky
NCTR
Author Profile

Abstract

Direct sequencing can be used for characterizing mutagenicity in complex biological models, e.g., in various tissues of mammalian species. We employed whole-genome High-Fidelity Sequencing (HiFi Sequencing) for detecting mutations induced in male CD-1 mice by N-ethyl-N-nitrosourea (ENU). Mice were treated by gavage with a single 40 mg/kg dose of ENU at 12 weeks of age; negative control mice were untreated. Peripheral blood and solid tissues (liver, spleen, and kidney) were harvested 4 weeks post-exposure; the erythrocyte Pig-a assay was used to measure mutant frequencies in peripheral blood, while mutations were evaluated in the solid tissues by HiFi Sequencing. The frequency of Pig-a phenotypically mutant total red blood cells and reticulocytes in ENU-treated mice increased 7- and 30-fold, while the frequency of mutations in the genomic DNA of solid tissues increased up to 7-fold, with the greatest increase observed in the spleen and the smallest increase in the liver. The most common mutations detected by HiFi Sequencing in ENU-treated mice were T>A transitions and T>C transversions. The data suggest that HiFi Sequencing complements the Pig-a reporter gene mutation assay, detecting mutagenicity in tissues where performing the Pig-a assay is impossible and providing information on the spectra of mutations which potentially may be useful for characterizing the genotoxicity of novel compounds.